All work performed by the Tumor Engineering and Phenotyping Shared Resource (TEP)  should be acknowledged in scholarly publications, posters, and presentations. Proper recognition allows us to measure the impact of our work and supports our initiatives in obtaining sponsored funding. In addition, any TEP personnel who makes a substantial intellectual or experimental contribution is deserving of further recognition as a co-author. Recent publications are listed where TP has authorship or TEP contribution is recognized.


  • Wang X, Shepherd S, Li N, Che C, Song T, Xiong Y, Palm IR, Zhao B, Kohli M, Demirci U, Lu Y, Cunningham BT. A Target Recycling Amplification Process for the Digital Detection of Exosomal MicroRNAs through Photonic Resonator Absorption Microscopy. Angew Chem Int Ed Engl. 2023 Apr 11;62(16):e202217932. doi: 10.1002/anie.202217932. Epub 2023 Mar 6. PMID: 36622783; PMCID: PMC10073263.
  • Hsieh PH, Phal Y, Prasanth KV, Bhargava R. Cell Phase Identification in a Three-Dimensional Engineered Tumor Model by Infrared Spectroscopic Imaging. Anal Chem. 2023 Feb 14;95(6):3349-3357. doi: 10.1021/acs.analchem.2c04554. Epub 2022 Dec 27. PMID: 36574385.
  • Kolliopoulos V, Dewey MJ, Polanek M, Xu H, Harley BAC. Amnion and chorion matrix maintain hMSC osteogenic response and enhance immunomodulatory and angiogenic potential in a mineralized collagen scaffold. Front Bioeng Biotechnol. 2022 Nov 14;10:1034701. doi: 10.3389/fbioe.2022.1034701. PMID: 36466348; PMCID: PMC9714677.